PKU HealthCare Corp Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PKU HealthCare Corp Ltd with three other
companies in this sector in China:
Shenzhen Hepalink Pharmaceutical Company Limited
sales of 2.26 billion Chinese Renmimbi [US$356.16 million]
of which 100%
was Pharmaceutical Manufacturing),
Changjiang Runfa Medicine Co Ltd
(2.11 billion Chinese Renmimbi [US$333.39 million]
of which 55%
was Medicine), and
Zhejiang Jingxin Pharmaceutical Co., Ltd.
(1.87 billion Chinese Renmimbi [US$295.53 million]
of which 57%
was Pharmaceutical Ingredient).
PKU HealthCare Corp Ltd reported sales of 2.07 billion Chinese Renmimbi (US$326.28 million)
December of 2016.
increase of 3.0%
versus 2015, when the company's sales were 2.01 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2014, when PKU HealthCare Corp Ltd
reported sales of 2.27 billion Chinese Renmimbi.
The sales level in 2016 was fairly close to the level five years ago: in 2011, PKU HealthCare Corp Ltd had sales
of 1.96 billion Chinese Renmimbi.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
62.8% in 2016, from
3.42 million Chinese Renmimbi to 5.56 million Chinese Renmimbi.
PKU HealthCare Corp Ltd also saw significant increases in sales in
Merchandise&material Selling (up 39.4% to 1.78 billion Chinese Renmimbi)
Not all segments of PKU HealthCare Corp Ltd experienced an increase in sales in 2016:
sales of Medicine Production fell 56.4% to 315.43 million Chinese Renmimbi.